Mr. Badr’s exceptional career and national reputation as a technology entrepreneur and IT executive, inspired him to see how artificial intelligence and machine learning technologies can add a lot of value to the existing healthcare billing practices & revenue cycle management.
Prior to founding Zollect, Mr. Badr was the CEO of siParadigm, a nationally recognized pathology lab with a mission to transform the lab into a digital, paperless enterprise that could rapidly scale both regionally and globally.
Mr. Badr was the founder of Vezeeta, a healthcare technology startup that is headquartered in Egypt and expanding aggressively in the middle east. Vezeeta was named one of the top 5 most successful start-ups in Egypt by Fortune Magazine. Mr. Badr was a cofounder and Chief Information Officer of ITWorx, a software development house serving clients all over the globe.
Seasoned business professional with 20+ years of in-depth experience in international business environments. Established track record in commercial management and business development of diversified oil and gas businesses including startup acquisitions, asset management and business mergers since 1999. Led multi-disciplinary teams in the delivery of several key acquisition, divestment and asset commercial restructuring transactions totaling in excess of $1Bn.
Dr. Nasr is a nationally recognized Hematopathologist and thought leader in high-complexity Oncology Diagnostics. His expertise in the area has made him a sought-after advisor around innovation, corporate strategy and development, and leadership in pathology and laboratory medicine.
Prior to founding siParadigm, he was the Medical Director of Quest Diagnostics (Teterboro, NJ) and Director of Specialty and Clinical Laboratories at St. Joseph’s Regional Medical Center (Paterson, NJ).
Paolo is a seasoned executive who served in public and private organizations. Paolo served as the Technical Secretary of the Ministry of Economy and Finance in Italy from 2002 to 2003. Paolo then focused on consultancy with specific interest in healthcare though his work as a Mckinsey partner for 12 years. Following that, currently he works as the General Manager of Health Development for Generali, one of the largest insurance firms in Europe. Paolo signed to be an advisor and independent director for Zollect in Jan 2019.
Youssri is a proven entrepreneur and investor who has successfully co-founded, operated and exited several startups globally including ITWorx. He brings 25+ years of experience in engineering, product, management, marketing and business development in a wide range of technologies to Eonite. Currently, Youssri sit on the board of Egypt Ventures and he is one of the renowned Angel investors at Zollect.
Fully automate and manage the revenue cycle through a HIPAA compliant end-to-end system handling insurance and patient billing through Artificial Intelligence technologies.
Optimizing the future of healthcare through innovative technology.
Zollect assists healthcare providers in recognizing lost revenue and lowering billing cost by bringing artificial intelligence and machine learning technologies to their practices. The use of Artificial Intelligence enabled solution will allow identification of complex denial patterns, automatically applying simple corrections to prevent denials and providing recommendations for billing teams to execute
Mr. Badr’s exceptional career and national reputation as a technology entrepreneur and IT executive, inspired him to see how artificial intelligence and machine learning technologies. Read more.
Seasoned business professional with 20+ years of in-depth experience in international business environments. Established track record in commercial management and business development. Read more.
Dr. Nasr is a nationally recognized Hematopathologist and thought leader in highcomplexity Oncology Diagnostics. Read more.
Paolo is a seasoned executive who served in public and private organizations. Paolo served as the Ministry… Read more.
Youssri is a proven entrepreneur and investor who has successfully cofounded, operated and exited several startups… Read more.